Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

On 24 September 2016, the Multiple Sclerosis Clinical Trials Unit hosted 102 patients and family members/carers at the Unipart Conference Centre in Oxford.

In the morning Dr Matthew Craner updated everyone on the topics presented at a recent MS conference and Dr Jacqueline Palace talked about the UK Risk Sharing Scheme, which helped make second-line treatments more available for patients with MS.

Fascinating set of presentations. Complicated sciences presented in an accessible and interesting way. Well done to all.
- Patient attendee

Several early-career researchers then presented the projects they are currently working on in the field of MS. During lunch there were posters from researchers detailing their research as well as an opportunity to get information leaflets from a local MS Society branch and sign up for the brain bank.

In the afternoon three key speakers gave detailed presentations on stem cells (Dr Andrew Weir), using clinical data to improve treatment of MS (Professor Paul Matthews), and genetics (Professor Lars Fugger).

 

Similar stories

Capturing immune cells that colonise the brain to prevent disease progression in multiple sclerosis

Clinical Neurology Research

Researchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.

Two neurologists awarded MRC Senior Clinical Fellowships

Clinical Neurology Research

Two of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.

Developing diagnostics for COVID-19

Clinical Neurology Coronavirus Research

Associate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.

COVID-19 and Guillain-Barré syndrome

Clinical Neurology Coronavirus Research

Multiple recent case reports have suggested a link between COVID-19 and Guillain-Barré syndrome (GBS), an acute, disabling, immune-mediated disorder of the peripheral nervous system. It is currently unclear whether this simply represents a chance association.

Viruses shown to evolve as a result of different immune responses in different ethnic populations

Clinical Neurology Coronavirus Research

New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.

Emerging Leaders Prize celebrates outstanding pain researchers

Award Clinical Neurology

2020’s Emerging Leaders Prize awards £200,000 to outstanding scientists from the University of Oxford, University College London and King’s College London, who are all working in the field of pain research.